Nomenclature	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2526	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2481	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2482	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2483	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2488
Common abbreviation	TPO	DIO1	DIO2	DIO3	IYD
HGNC, UniProt	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:12015, http://www.uniprot.org/uniprot/P07202	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:2883, http://www.uniprot.org/uniprot/P49895	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:2884, http://www.uniprot.org/uniprot/Q92813	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:2885, http://www.uniprot.org/uniprot/P55073	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:21071, http://www.uniprot.org/uniprot/Q6PHW0
EC number	http://www.genome.jp/dbget‐bin/www_bget?ec:1.11.1.8: [Thyroglobulin]‐L‐tyrosine + http://www.genome.jp/dbget‐bin/www_bget?ec:1.97.1.10 + H+ + I‐ ‐> [Thyroglobulin]‐3,5,3′‐triiodo‐L‐thyronine + [thyroglobulin]‐aminoacrylate + H2O	http://www.genome.jp/dbget‐bin/www_bget?ec:1.97.1.10: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2635 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2634 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2636 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6648	http://www.genome.jp/dbget‐bin/www_bget?ec:1.97.1.10: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2635 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2634 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2636 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6648	http://www.genome.jp/dbget‐bin/www_bget?ec:1.97.1.11: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2635 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2634 http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2636 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6648	http://www.genome.jp/dbget‐bin/www_bget?ec:1.22.1.1: http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5117 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4791 + I‐ http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6651 ‐> http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5117 + I‐
Cofactors	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=707	–	–	–	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5184, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3041
Inhibitors	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6649 [http://www.ncbi.nlm.nih.gov/pubmed/748042?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6650 [http://www.ncbi.nlm.nih.gov/pubmed/748042?dopt=AbstractPlus]	–	–	–	–
Comments	Carbimazole is a pro‐drug for http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6649	–	–	–	–